Properties of astrocytes cultured from GFAP over-expressing and GFAP mutant mice

Experimental Cell Research

Volumn 315, Issue 7, 2009, Pages 1260-1272

  Cho, Woosung ^a   Messing, Albee ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Alexander disease; Astrocytes; Glial fibrillary acidic protein (GFAP); Rosenthal fiber (RF)

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEASOME;

ALEXANDER DISEASE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL CULTURE; CELL DEATH; CELL FUNCTION; CELL INCLUSION; CELL PROLIFERATION; CELL STRESS; CONTROLLED STUDY; CYTOSKELETON; GENE LOCUS; GENE MUTATION; MOUSE; MUTANT; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; WILD TYPE;

MUS;

ALEXANDER DISEASE; ALPHA-CRYSTALLIN B CHAIN; ANIMALS; ASTROCYTES; CASPASES; CELL DEATH; CELLS, CULTURED; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; HYDROGEN PEROXIDE; MICE; MICE, TRANSGENIC; MUTATION; OXIDANTS; OXIDATIVE STRESS; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 63049138899     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.12.012     Document Type: Article

References (64)

1. Brenner M., Johnson A.B., Boespflug-Tanguy O., Rodriguez D., Goldman J.E., and Messing A. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat. Genet. 27 (2001) 117-120
2. van der Knaap M.S., Naidu S., Breiter S.N., Blaser S., Stroink H., Springer S., Begeer J.C., Van Coster R., Barth P.G., Thomas N.H., Valk J., and Powers J.M. Alexander disease: diagnosis with MR imaging. Am. J. Neuroradiol. 22 (2001) 541-552
3. Alexander W.S. Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic infant. Brain 72 (1949) 373-381
4. Iwaki T., Kume-Iwaki A., Liem R.K.H., and Goldman J.E. B-Crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain. Cell 57 (1989) 71-78
5. Johnson A.B., and Bettica A. On-grid immunogold labeling of glial intermediate filaments in epoxy-embedded tissue. Am. J. Anat. 185 (1989) 335-341
6. Head M.W., Corbin E., and Goldman J.E. Overexpression and abnormal modification of the stress proteins alpha B-crystallin and HSP27 in Alexander disease. Am. J. Pathol. 143 (1993) 1743-1753
7. Zatloukal K., Stumptner C., Fuchsbichler A., Heid H., Schnoelzer M., Kenner L., Kleinert R., Prinz M., Aguzzi A., and Denk H. p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am. J. Pathol. 160 (2002) 255-263
8. Tian R.J., Gregor M., Wiche G., and Goldman J.E. Plectin regulates the organization of glial fibrillary acidic protein in Alexander disease. Am. J. Pathol. 168 (2006) 888-897
9. Rosenthal W. Über eine eigenthümliche, mit syringomyelie complicirte geschwulst des rückenmarks. Bietr. Pathol. Anat. 23 (1898) 111-143
10. Herndon R.M., Rubinstein L.J., Freeman J.M., and Mathieson G. Light and electron microscopic observations on Rosenthal fibers in Alexander's disease and in multiple sclerosis. J. Neuropathol. Exp. Neurol. 29 (1970) 524-551
11. Grcevic N., and Yates P.O. Rosenthal fibres in tumours of the central nervous system. J. Path. Bact. 73 (1957) 467-472
12. Wippold F.J., Perry A., and Lennerz J. Neuropathology for the neuroradiologist: Rosenthal fibers. Am. J. Neuroradiol. 27 (2006) 958-961
13. Messing A., Head M.W., Galles K., Galbreath E.J., Goldman J.E., and Brenner M. Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice. Am. J. Pathol. 152 (1998) 391-398
14. Mignot C., Boespflug-Tanguy O., Gelot A., Dautigny A., Pham-Dinh D., and Rodriguez D. Alexander disease: putative mechanisms of an astrocytic encephalopathy. Cell. Mol. Life Sci. 61 (2004) 369-385
15. Messing A., and Brenner M. Models of Alexander disease. In: Lazzarini R.A. (Ed). Myelin Biology and Disorders 2 (2004), Elsevier, Amsterdam 1115-1124
16. Li R., Johnson A.B., Salomons G., Goldman J.E., Naidu S., Quinlan R., Cree B., Ruyle S.Z., Banwell B., D'Hooghe M., Siebert J.R., Rolf C.M., Cox H., Reddy A., Gutiérrez-Solana L.G., Collins A., Weller R.O., Messing A., van der Knaap M.S., and Brenner M. GFAP mutations in infantile, juvenile, and adult forms of Alexander disease. Ann. Neurol. 57 (2005) 310-326
17. Quinlan R.A., Brenner M., Goldman J., and Messing A. GFAP and its role in Alexander disease. Exp. Cell Res. 313 (2007) 2077-2087
18. Koyama Y., and Goldman J.E. Formation of GFAP cytoplasmic inclusions in astrocytes and their disaggregation by αB-crystallin. Am. J. Pathol. 154 (1999) 1563-1572
19. Hsiao V.C., Tian R., Long H., Der Perng M., Brenner M., Quinlan R.A., and Goldman J.E. Alexander-disease mutation of GFAP causes filament disorganization and decreased solubility of GFAP. J. Cell Sci. 118 (2005) 2057-2065
20. Perng M.D., Su M., Wen S.F., Li R., Gibbon T., Prescott A.R., Brenner M., and Quinlan R.A. The Alexander disease-causing GFAP mutant, R416W, accumulates into Rosenthal fibers by a pathway involving filament aggregation and the association of αB-crystallin and HSP27. Am. J. Hum. Genet. 79 (2006) 197-213
21. Tang G., Xu Z., and Goldman J.E. Synergistic effects of the SAPK/JNK and the proteasome pathway on glial fibrillary acidic protein (GFAP) accumulation in Alexander disease. J. Biol. Chem. 281 (2006) 38634-38643
22. Hagemann T.L., Connor J.X., and Messing A. Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response. J. Neurosci. 26 (2006) 11162-11173
23. Tanaka K.F., Takebayashi H., Yamazaki Y., Ono K., Naruse M., Iwasato T., Itohara S., Kato H., and Ikenaka K. The murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance. Glia 55 (2007) 617-631
24. Hagemann T.L., Gaeta S.A., Smith M.A., Johnson D.A., Johnson J.A., and Messing A. Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction. Hum. Mol. Genet. 14 (2005) 2443-2458
25. Eng L.F., Lee Y.L., Kwan H., Brenner M., and Messing A. Astrocytes cultured from transgenic mice carrying the added human glial fibrillary acidic protein gene contain Rosenthal fibers. J. Neurosci. Res. 53 (1998) 353-360
26. Vassar R., Coulombe P.A., Degenstein L., Albers K., and Fuchs E. Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease. Cell 64 (1991) 365-380
27. Bär H., Fischer D., Goudeau B., Kley R.A., Clemen C.S., Vicart P., Herrmann H., Borgerd M., and Schröder R. Pathogenic effects of a novel heterozygous R350P desmin mutation on the assembly of desmin intermediate filaments in vivo and in vitro. Hum. Mol. Genet. 14 (2005) 1251-1260
28. Kitamura Y., Ota T., Matsuoka Y., Tooyama I., Kimura H., Shimohama S., Nomura, Gebicke-Haerter P.J., and Taniguchi T. Hydrogen peroxide-induced apoptosis mediated by p53 protein in glial cells. Glia 25 (1999) 154-164
29. Tang G., Yue Z., Talloczy Z., Hagemann T., Cho W., Messing A., Sulzer D.L., and Goldman J.E. Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways. Hum. Mol. Genet. 17 (2008) 1540-1555
30. Sullivan S.M., Lee A., Björkman S.T., Miller S.M., Sullivan R.K.P., Poronnik P., Colditz P.B., and Pow D.V. Cytoskeletal anchoring of GLAST determines susceptibility to brain damage - an identified role for GFAP. J. Biol. Chem. 282 (2007) 29414-29423
31. Goldman J.E., and Chiu F.C. Growth kinetics, cell shape, and the cytoskeleton of primary astrocyte cultures. J. Neurochem. 42 (1984) 175-184
32. Goldman J.E., and Abramson B. Cyclic AMP-induced shape changes of astrocytes are accompanied by rapid depolymerization of actin. Brain Res. 528 (1990) 189-196
33. Xu W.M., Baribault H., and Adamson E.D. Vinculin knockout results in heart and brain defects during embryonic development. Development 125 (1998) 327-337
34. Howe A., Aplin A.E., Alahari S.K., and Juliano R.L. Integrin signaling and cell growth control. Curr. Opin. Cell Biol. 10 (1998) 220-231
35. Yoshida T., Tomozawa Y., Arisato T., Okamoto Y., Hirano H., and Nakagawa M. The functional alteration of mutant GFAP depends on the location of the domain: morphological and functional studies using astrocytoma-derived cells. J. Hum. Genet. 52 (2007) 362-369
36. Egnaczyk G.F., Pomonis J.D., Schmidt J.A., Rogers S.D., Peters C., Ghilardi J.R., Mantyh P.W., and Maggio J.E. Proteomic analysis of the reactive phenotype of astrocytes following endothelin-1 exposure. Proteomics 3 (2003) 689-698
37. Perng M.D., Cairns L., van den IJssel P., Prescott A., Hutcheson A.M., and Quinlan R.A. Intermediate filament interactions can be altered by HSP27 and αB-crystallin. J. Cell Sci. 112 (1999) 2099-2112
38. Bennardini F., Wrzosek A., and Chiesi M. Alpha B-crystallin in cardiac tissue. Association with actin and desmin filaments. Circ. Res. 71 (1992) 288-294
39. Nicholl I.D., and Quinlan R.A. Chaperone activity of α-crystallins modulates intermediate filament assembly. EMBO J. 13 (1994) 945-953
40. Tseng W.C., Lu K.S., Lee W.C., and Chien C.L. Redistribution of GFAP and αB-crystallin after thermal stress in C6 glioma cell line. J. Biomed. Sci. 13 (2006) 681-694
41. Ousman S.S., Tomooka B.H., van Noort J.M., Wawrousek E.F., O'Conner K., Hafler D.A., Sobel R.A., Robinson W.H., and Steinman L. Protective and therapeutic role for αB-crystallin in autoimmune demyelination. Nature 448 (2007) 474-479
42. Rutka J.T., and Smith S.L. Transfection of human astrocytoma cells with glial fibrillary acidic protein complementary DNA: analysis of expression, proliferation, and tumorigenicity. Cancer Res. 53 (1993) 3624-3631
43. Rutka J.T., Hubbard S.L., Fukuyama K., Matsuzawa K., Dirks P.B., and Becker L.E. Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion, and adhesion of human astrocytoma cells. Cancer Res. 54 (1994) 3267-3272
44. Toda M., Miura M., Asou H., Sugiyama I., Kawase T., and Uyemura K. Suppression of glial tumor growth by expression of glial fibrillary acidic protein. Neurochem. Res. 24 (1999) 339-343
45. Pekny M., Eliasson C., Chien C.L., Kindblom L.G., Liem R., Hamberger A., and Betsholtz C. GFAP-deficient astrocytes are capable of stellation in vitro when cocultured with neurons and exhibit a reduced amount of intermediate filaments and an increased saturation density. Exp. Cell Res. 239 (1998) 332-343
46. Hyder C.L., Pallari H.M., Kochin V., and Eriksson J.E. Providing cellular signposts-post-translational modifications of intermediate filaments. FEBS Lett. 582 (2008) 2140-2148
47. Nishizawa K., Yano T., Shibata M., Ando S., Takahashi T., and Inagaki M. Specific localization of phosphointermediate filament protein in the constricted area of dividing cells. J. Biol. Chem. 266 (1991) 3074-3079
48. Ku N.O., and Omary M.B. A disease- and phosphorylation-related nonmechanical function for keratin 8. J. Cell Biol. 174 (2006) 115-125
49. Kosako H., Amano M., Yanagida M., Tanabe K., Nishi Y., Kaibuchi K., and Inagaki M. Phosphorylation of glial fibrillary acidic protein at the same sites by cleavage furrow kinase and Rho-associated kinase. J. Biol. Chem. 272 (1997) 10333-10336
50. Mignot C., Delarasse C., Escaich S., della Gaspera B., Noe E., Colucci-Guyon E., Babinet C., Pekny M., Vicart P., Boespflug-Tanguy O., Dautigny A., Rodriguez D., and Pham-Dinh D. Dynamics of mutated GFAP aggregates revealed by real-time imaging of an astrocyte model of Alexander disease. Exp. Cell Res. 313 (2007) 2766-2779
51. Li H.H. 14-3-3 gamma affects dynamics and integrity of glial filaments by binding to phosphorylated GFAP. J. Cell Sci. 119 (2006) 4452-4461
52. Kim S., Wong P., and Coulombe P.A. A keratin cytoskeletal protein regulates protein synthesis and epithelial cell growth. Nature 441 (2006) 362-365
53. Kamradt M.C., Chen F., and Cryns V.L. The small heat shock protein αB-crystallin negatively regulates cytochrome c- and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation. J. Biol. Chem. 276 (2001) 16059-16063
54. Mao Y.W., Liu J.P., Xiang H., and Li D.W. Human αA- and αB-crystallins bind to Bax and Bcl-Xs to sequester their translocation during staurosporine-induced apoptosis. Cell Death Differ. 11 (2004) 512-526
55. Li D.W., Liu J.P., Mao Y.W., Xiang H., Wang J., Ma W.Y., Dong Z., Pike H.M., Brown R.E., and Reed J.C. Calcium-activated RAF/MEK/ERK signaling pathway mediates p53-dependent apoptosis and is abrogated by αB-crystallin through inhibition of RAS activation. Mol. Biol. Cell 16 (2005) 4437-4453
56. Mouser P.E., Head E., Ha K.H., and Rohn T.T. Caspase-mediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer's disease brain. Am. J. Pathol. 168 (2006) 936-946
57. Acarin L., Villapol S., Faiz M., Rohn T.T., Castellano B., and Gonzalez B. Caspase-3 activation in astrocytes following postnatal excitotoxic damage correlates with cytoskeletal remodeling but not with cell death or proliferation. Glia 55 (2007) 954-965
58. Oshima R.G. Apoptosis and keratin intermediate filaments. Cell Death Differ. 9 (2002) 486-492
59. Kim S., and Coulombe P.A. Intermediate filament scaffolds fulfill mechanical, organizational, and signaling functions in the cytoplasm. Genes Dev. 21 (2007) 1581-1597
60. Messing A., and Goldman J.E. Alexander disease. In: Lazzarini R.A. (Ed). Myelin Biology and Disorders 2 (2004), Elsevier, Amsterdam 851-866
61. Wakabayashi N., Itoh K., Wakabayashi J., Motohashi H., Noda S., Takahashi S., Imakado S., Kotsuji T., Otsuka F., Roop D.R., Harada T., Engel J.D., and Yamamoto M. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat. Genet. 35 (2003) 238-245
62. Magin T.M. A keaper and a striker maintain epidermal homeostasis. Nat. Genet. 35 (2003) 202-204
63. 2-induced apoptosis through down-regulation of the αB-crystallin gene. J. Biol. Chem. 276 (2001) 43435-43445
64. Blanc E.M., Keller J.N., Fernandez S., and Mattson M.P. 4-hydroxynonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes. Glia 22 (1998) 149-160